Celltrion Health Care Co.,Ltd. is engaged in distributing and selling of biosimilar and biological medicines. The company offers products such as Remsima, a biosimilar monoclonal antibody used for the treatment of crohn's disease, ulcerative colitis, rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. Celltrion Health Care Co.,Ltd. also provides Truxima, a biosimilar rituximab medication used for the treatment of non-hodgkin’s lymphoma, chronic lymphocytic leukemia, RA, granulomatosis with polyangiitis, and microscopic polyangiitis. The company was formerly known as Nexol, Inc. Celltrion Health Care Co.,Ltd. was incorporated in 1999 and is based in Incheon, South Korea.
4th Floor, 19, Academy-ro 51beon-gil Yeonsu-gu Incheon
Incheon; Incheon; Postal Code: 406840
Contact Details: Purchase the Celltrion Health Care Co.,Ltd. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service